Dr. Pei Ing Ngam Singapore

Dr. Ngam Pei Ing is a Consultant in Nuclear Medicine and Diagnostic Imaging at the National University Hospital (NUH), Singapore, where she serves as the institutional lead for theranostics. Dr. Ngam is also an Executive Committee member of Nuclear Medicine Society Singapore and is actively involved in advancing molecular imaging and theranostic practice in the region. Her clinical and research interests focus on the integration of molecular imaging and targeted radionuclide therapy in oncology. She leads theranostic programs involving PSMA-targeted radioligand therapy for prostate cancer and peptide receptor radionuclide therapy for neuroendocrine tumours, with a particular interest in multimodal imaging biomarkers, and the novel dynamic and quantitative PET imaging. Through her clinical, research, and academic activities, Dr. Ngam aims to advance precision medicine through molecular imaging and theranostics.

17 July: M3 - PSMA-Targeted Radioligand Therapy: From Evidence to Clinical Implementation - Masterclass

Time Session
10:35
11:05
Session 1: Revolutionizing Prostate Cancer Care with PSMA-Targeted Theranostics
EdmundChiong Moderator Singapore
11:05
11:50
Session 2: The Multidisciplinary Journey of an mCRPC Patient Receiving Lu-PSMA-RLT
EdmundChiong Moderator Singapore
11:50
12:15
Session 3: Interactive Case Series